Ristamaki et al. [4] also confirmed that the elevated COX-2 expression seen in 37.4% of the 1567 invasive breast cancers were associated with a large tumor size, high tumor grade, negative estrogen receptor status, high p53 expression and unfavorable prognosis. The gene discussed is TP53; the disease is neoplasm.